Stay updated on STK-012 in Solid Tumors with Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the STK-012 in Solid Tumors with Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the STK-012 in Solid Tumors with Pembrolizumab Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page displays Revision: v3.5.4, replacing the previous v3.5.3. This indicates a new ClinicalTrials.gov release rather than changes to the study details.
    Difference
    0.1%
    Check dated 2026-05-15T02:13:44.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page's revision history shows a new version, v3.5.3, added to the records. This reflects a small system update rather than substantive changes to study information.
    Difference
    0.1%
    Check dated 2026-04-30T18:37:11.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    A new revision entry v3.5.2 was added to the history, replacing the previous v3.5.0 entry.
    Difference
    0.1%
    Check dated 2026-04-16T10:40:42.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Record History now shows per-version changes for Study Status and Contacts/Locations (Revision: v3.5.0, added 2026-03-17/18).
    Difference
    0.5%
    Check dated 2026-03-18T17:57:53.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    A new revision entry v3.4.3 was added and the previous v3.4.2 was removed from the record history. This update affects revision tracking rather than study content.
    Difference
    0.1%
    Check dated 2026-03-11T16:59:01.000Z thumbnail image
  8. Check
    101 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added to the history. The funding-lapse notice and the earlier revision note (v3.4.1) were removed.
    Difference
    0.7%
    Check dated 2026-02-11T02:17:34.000Z thumbnail image

Stay in the know with updates to STK-012 in Solid Tumors with Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the STK-012 in Solid Tumors with Pembrolizumab Clinical Trial page.